Anemia Screening
Anemia Screening - Related Videos
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
0 Views •
2015
Here we describe a cell-based reporter gene assay as a valuable tool to screen chemical libraries for compounds modulating post-transcriptional control mechanisms exerted through 3’ UTR.
08:50
Genetic Screens
0 Views •
2023
Genetic screens are critical tools for defining gene function and understanding gene interactions. Screens typically involve mutating genes and then assessing the affected organisms for phenotypes of interest. The process can be “forward”, where mutations are generated randomly to identify unknown genes responsible for the phenotypes, or it can be “reverse”, where specific genes are targeted for mutation to observe what phenotypes are produced.Here, JoVE reviews various types of genetic...
08:10
Multi-enzyme Screening Using a High-throughput Genetic Enzyme Screening System
0 Views •
Cited by 7 •
2016
This work presents a method of high-throughput screening using a universal genetic enzyme screening system that can be theoretically applied to over 200 enzymes. Here, the single screening system identifies three different enzymes (lipase, cellulase, and alkaline phosphatase) by simply changing the substrate used (p-nitrophenyl acetate, p-nitrophenyl-β-D-cellobioside, and phenyl phosphate).
06:40
A Robust Method for the Large-Scale Production of Spheroids for High-Content Screening and Analysis Applications
0 Views •
Cited by 4 •
2021
This protocol details a method for the production of three different types of spheroids in a manner that makes them suitable for large-scale high-content screening and analysis. In addition, examples are presented showing how they can be analyzed at spheroid and individual cell levels.
05:35
A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
0 Views •
Cited by 3 •
2024
An accurate hemoglobin estimation method is lacking at the point of care and may hinder population-based programs for treating anemia. Therefore, we developed a point-of-care method based on pooled capillary blood and an auto-analyzer integrated into a custom software application to categorize the hemoglobin values into different grades of anemia.
FAQs
Hemoglobin and hematocrit provide complementary measurements in the initial blood evaluation. Hemoglobin helps assess the blood’s oxygen-carrying capacity, while hematocrit adds information about the red blood cell component measured in the sample. Considering both values can support recognition of reduced oxygen delivery and establish a baseline for later comparison during follow-up.
Red blood cell indices refine the information obtained from a complete blood count by describing features such as cell size and hemoglobin content. These patterns can make an abnormal result more interpretable and help direct follow-up testing. In biology and clinical research, this characterization supports comparison among different forms of anemia rather than treating every result as identical.
Follow-up testing can investigate several possible explanations for an abnormal result, including iron deficiency, vitamin deficiencies, chronic disease, blood loss, and inherited disorders. This step moves the evaluation beyond detecting reduced oxygen-carrying capacity toward identifying a possible cause. Distinguishing among these causes is important because the screening result alone does not explain why the abnormality occurred.
Screening can identify reduced oxygen-carrying capacity before symptoms become evident, allowing an abnormal finding to receive further evaluation earlier. This is particularly relevant when studying populations considered at risk for impaired oxygen delivery. Early identification can support diagnostic decisions and create an opportunity to monitor whether the abnormality changes during subsequent care or research observation.
The evaluation commonly begins with a complete blood count measuring hemoglobin and hematocrit, with red blood cell indices added to characterize the result. If the findings suggest an abnormality, follow-up tests can investigate potential causes such as nutrient deficiency, chronic disease, blood loss, or inherited disorders. This sequence separates initial detection from more specific cause assessment.
Repeated measurements can show whether blood-related findings remain abnormal, change over time, or respond to treatment. Hemoglobin, hematocrit, and red blood cell indices provide markers for comparing these changes, while follow-up testing can clarify whether the underlying cause also changes. Such results help evaluate treatment responses and monitor anemia-related patterns in study populations.
In biology and clinical research, anemia screening supports early detection, diagnostic decision-making, and monitoring across populations at risk of impaired oxygen delivery. Researchers can use the initial blood measurements to identify patterns, examine red blood cell characteristics, and select appropriate follow-up investigations. The resulting data can also help assess how abnormalities evolve or respond to treatment.